Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer. - Propper, D J; Levitt, N C; O’Byrne, K; Braybrooke, J P; Talbot, D C; Ganesan, T S; Thompson, C H; Rajagopalan, B; Littlewood, T J; Dixon, R M; Harris, A L (British Journal of Cancer, 2000)